Morningstar

iMDx to Release Third Quarter Results on November 16, 2026

Provided by GlobeNewswire

NASHVILLE, Tenn., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report third quarter 2026 financial results after the market closes on Monday, November 16, 2026. iMDx will host a live Zoom webinar to discuss the company's financial results at 2:00 pm PT / 5:00 pm ET that same day.

The live webinar to discuss financial results, followed by Q&A, will be accessible via registration at the following link: iMDx Q3 2026 Earnings Webinar.

An archived replay will be available after the call concludes on iMDx’s website within the Investors/Events & Presentations section.

About Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information.

GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.

Investor Contact:
Alexandra Grossman
LifeSci Advisors LLC
imdx@lifesciadvisors.com 



The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

3 Stocks to Sell and 3 Stocks to Buy for November

Plus, whether Microsoft, Alphabet, or Amphenol look attractive after earnings.
David Sekera, CFA and Sarah Hansen

3 of the Best Dividend Stocks to Own

These dividend stocks with economic moats offer durable payouts.
Susan Dziubinski

These Overvalued Stocks Have Plenty of Room to Fall

Why investors should be wary of a refiner and financial-services stock trading well above our fair value estimates.
David Sekera, CFA, Sarah Hansen, and Jess Bebel

4 Big Impacts from the US Midterm Elections for Investors

What analysts are saying the blue wave means for the AI trade, the debt ceiling, and Democrats’ legislative priorities.
Sarah Hansen

US Midterms: How Markets Are Reacting to Democrats’ Congressional Gains

Stocks, bonds, and gold are moving as the Republican Party loses the Senate and House.
Karen Gilchrist and Vicky McKeever

Sponsor Center

Site Index
United States Flag United States

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.